Company Filing History:
Years Active: 2016-2017
Title: Ingar Leiros: Innovator in Endonuclease Technology
Introduction
Ingar Leiros is a notable inventor based in Tromsø, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of endonucleases. With a total of 2 patents to his name, Leiros continues to push the boundaries of scientific innovation.
Latest Patents
Leiros' latest patents focus on endonucleases, specifically providing an endonuclease I or enzymatically active fragment thereof. These inventions include sequences that are at least 70% identical to SEQ ID No. 4, with specific modifications to the amino acid residues. The patents also detail methods for removing contaminating polynucleotides from samples using these enzymes, showcasing the practical applications of his work in molecular biology.
Career Highlights
Ingar Leiros is currently associated with Biotec Pharmacon ASA, where he applies his expertise in enzyme technology. His work has been instrumental in advancing the understanding and application of endonucleases in various scientific fields.
Collaborations
Leiros collaborates with talented individuals such as Olav Lanes and Linda Havdalen. These partnerships enhance the innovative environment at Biotec Pharmacon ASA and contribute to the success of their projects.
Conclusion
Ingar Leiros stands out as a key figure in the biotechnology sector, particularly for his advancements in endonuclease technology. His contributions continue to impact the scientific community positively.